Bone Resorption, Osteoclastogenesis and Adalimumab

NCT00814866 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Adalimumab

Sponsor

Université de Sherbrooke

Collaborators

[object Object]